# iRegene completes equity financing

On 2026-08-18, according to Xiniu Data, iRegene completed equity financing for an undisclosed amount. Investors were Sichuan Shengchengguozhuanhua Investment Yindao Fund Partnership (Limited Partnership), Chengdu Hongsheng Phase One Venture Capital Partnership (Limited Partnership), Wuxi City Biotechnology Pharmaceutical Industry Fund (Limited Partnership), Shenzhen City Pengyuanjishi Private Equity Investment Fund Partnership (Limited Partnership), Chengdu Weilai Industry Venture Capital Development Fund Partnership (Limited Partnership), Shanghai Dingtaixing Technology Development Co., Ltd.. The company is a developer of chemically induced cell therapy drugs.



Canonical: https://uniquebase.ai/news/e37154eb-94be-495a-ab4e-09c59b06a289
Stable identifier: e37154eb-94be-495a-ab4e-09c59b06a289
Snapshot captured: 2026-10-15T16:47:01.523Z
English updated: 2026-10-15T20:50:21.957Z

## Connected profiles

- [Chengdu Hongsheng Phase One Venture Capital Partnership (Limited Partnership)](/institutions/chengdu-hongsheng-phase-one-venture-capital-partnership-limited-partnership)
- [Chengdu Weilai Industry Venture Capital Development Fund Partnership (Limited Partnership)](/institutions/chengdu-weilai-industry-venture-capital-development-fund-partnership-limited-partnership)
- [Shanghai Dingtaixing Technology Development Co., Ltd.](/institutions/shanghai-dingtaixing-technology-development-co-ltd)
- [Shenzhen City Pengyuanjishi Private Equity Investment Fund Partnership (Limited Partnership)](/institutions/shenzhen-city-pengyuanjishi-private-equity-investment-fund-partnership-limited-partnership)
- [Sichuan Shengchengguozhuanhua Investment Yindao Fund Partnership (Limited Partnership)](/institutions/sichuan-shengchengguozhuanhua-investment-yindao-fund-partnership-limited-partnership)
- [Wuxi City Biotechnology Pharmaceutical Industry Fund (Limited Partnership)](/institutions/wuxi-city-biotechnology-pharmaceutical-industry-fund-limited-partnership)
- [iRegene](/companies/UB-C5987)

## Sources

- No source links are available for this profile.